Pershing Square Foundation MIND Prize: Sponsor Letter of Intent Deadline

Pershing Square Foundation MIND (Maximizing Innovation in Neuroscience Discovery) Prize
FAS/SEAS/OSP Deadline (LOIs require OSP review): December 5, 2022
Sponsor Letter of Intent Deadline: December 12, 2022 by 5 PM
Award Amount: $250,000/year for three years

The Pershing Square Foundation’s (PSF) brain initiative funds cutting-edge research that revolutionizes our ability to predict, prevent, and treat neurodegenerative diseases (NDDs). Advancing our fundamental understanding of the brain and cognition to ultimately combat neurodegeneration and related diseases is a goal of increasing urgency. Breakthroughs in basic scientific and translational research will yield critical tools for and knowledge of NDDs, including Alzheimer’s Disease and Dementia, which affect millions of people worldwide. The MIND (Maximizing Innovation in Neuroscience Discovery) Prize supports and empowers early-to-mid-career investigators to rethink conventional paradigms around NDDs. Principal Investigators must hold faculty appointments at academic research institutions in the U.S. and must have completed at least one but no more than ten years of independent research experience by the start date of the prize (May 2023).

The foundation seeks high-risk, high-reward proposals that focus on novel interdisciplinary approaches to neuroscience research and are grounded in sound reasoning from first principles. The MIND Prize was created to fund projects that have been deemed too risky or speculative for traditional funding sources but still hold the potential for radical impact. Projects may range from the invention of novel tools, techniques, and technologies for mapping and analyzing the brain to bold approaches that demonstrate extraordinary therapeutic potential. Research domains may include—but are not limited to—neurobiology, brain imaging and mapping, machine learning, drug delivery, and synthetic biology.